Curative Biotechnology, Inc. (CUBT)
OTCMKTS · Delayed Price · Currency is USD
0.0074
+0.0004 (5.60%)
Oct 22, 2025, 12:36 PM EDT
Curative Biotechnology Market Cap
Curative Biotechnology has a market cap or net worth of $7.52 million as of October 22, 2025. Its market cap has decreased by -50.76% in one year.
Market Cap
7.52M
Enterprise Value
10.41M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since February 22, 2008, Curative Biotechnology's market cap has decreased from 22.36M to 7.52M, a decrease of -66.37%. That is a compound annual growth rate of -5.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2025 | 7.52M | -36.11% |
| Dec 31, 2024 | 11.77M | -12.66% |
| Dec 29, 2023 | 13.47M | 17.84% |
| Dec 30, 2022 | 11.43M | -61.12% |
| Dec 31, 2021 | 29.41M | 201.64% |
| Dec 31, 2020 | 9.75M | 1,242.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 804.99M |
| Elite Pharmaceuticals | 644.08M |
| Glass House Brands | 624.73M |
| Silence Therapeutics | 349.53M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 326.28M |
| Northwest Biotherapeutics | 324.50M |
| American Oncology Network | 289.95M |